Flexion Therapeutics
208 articles about Flexion Therapeutics
-
Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer
5/20/2013
-
Data Presented at OARSI's 2013 World Congress on Osteoarthritis Show Flexion Therapeutics's FX006 Has Prolonged Therapeutic Concentration in Knee Joint
4/19/2013
-
Flexion Therapeutics to Present at 31st Annual J.P. Morgan Healthcare Conference
1/4/2013
-
Flexion Therapeutics's FX006 Achieves Prolonged Therapeutic Concentrations in Joints of Osteoarthritis Patients
12/17/2012
-
Flexion Therapeutics Names Arthur Fratamico Chief Business Officer
6/20/2012
-
Flexion Therapeutics Reports Positive Data for Osteoarthritis Drug
5/31/2012
-
Flexion Therapeutics Announces Agreements with Four Major Pharmaceutical Companies Such As AstraZeneca PLC (JOBS) And Merck Serono (JOBS); Closes Series A Financing Round At $42 Million
1/29/2010
-
Flexion Therapeutics Raises $33 Million in Series A Financing
10/19/2009